$TLRY 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Tilray is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 17 countries spanning five continents.

Sector

Manufacturing

Industry

Medicinal and Botanical Manufacturing

Employees

1030

CEO

Brendan Kennedy

Exchange

NASDAQ

Website

www.tilray.com

$513M

Total Revenue

1K

Employees

$3B

Market Capitalization

-9.74

Price/Earning ratio

Industry Peers

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Conversion Labs Inc CVLB 108548 35213 3.74 42.66 7.33
Royalty Pharma plc RPRX 19327 2239 2.87 15.52 43.40
Organon & Co. OGN 8644 7891 -4.46 4.95 22.06
Arvinas Inc ARVN 4342 21 8.14 -26.29 -782.93
Tilray Inc TLRY 3286 513 1.23 -9.74 -71.61
ATAI Life Sciences N.V. ATAI 2545 20 5.35 -11.65 -932.88
Cronos Group Inc CRON 2114 57 1.33 -14.64 -258.59
Usana Health Sciences Inc USNA 1837 1254 4.18 13.23 11.09
Phathom Pharmaceuticals Inc PHAT 1178 7.99 -7.35 None
Fulcrum Therapeutics Inc FULC 925 15 11.21 -12.53 -481.07
Intersect ENT Inc XENT 899 103 21.80 -13.10 -66.55
Phibro Animal Health Corp. PAHC 888 833 3.68 16.16 6.53
Edgewise Therapeutics Inc EWTX 848 2.87 -31.45 None
Pliant Therapeutics Inc PLRX 657 13 2.69 -7.66 -613.56
Cyteir Therapeutics Inc CYT 637 3.42 -22.04 None
Urovant Sciences Ltd UROV 503 -3.65 -3.08 None
Ikena Oncology Inc IKNA 467 10 2.52 -8.53 -551.28
Chromadex Corp CDXC 433 62 10.92 -18.30 -37.51
Rain Therapeutics Inc RAIN 404 413 2.50 -13.27 123.20
Provention Bio Inc PRVB 400 2.68 -3.12 None
Evolus Inc EOLS 321 77 4.24 -2.15 -171.53
Verrica Pharmaceuticals Inc VRCA 316 12 6.41 -8.69 -301.45
Terns Pharmaceuticals Inc TERN 263 1.46 -7.62 None
Adicet Bio Inc ACET 230 9 1.00 -4.09 -603.06
Milestone Pharmaceuticals Inc MIST 222 15 1.25 -7.50 -215.93
Kaleido Biosciences Inc KLDO 222 1 4.94 -2.49 None
LifeMD Inc LFMD 201 64 -28.62 -1.44 -133.55
Kala Pharmaceuticals Inc KALA 187 11 2.42 -1.48 None
Osmotica Pharmaceuticals Plc OSMT 181 190 2.64 -1.95 -47.85
Citius Pharmaceuticals Inc CTXR 177 2.21 -7.70 None
scPharmaceuticals Inc SCPH 162 119 2.38 -5.36 -27.05
Aquestive Therapeutics Inc AQST 146 42 -3.02 -2.27 -152.73
Eton Pharmaceuticals Inc ETON 123 15 6.11 -10.06 -74.52
Odonate Therapeutics Inc ODT 117 1.47 -1.00 None
Eyenovia Inc EYEN 113 6 12.86 -5.77 -324.94
Aerpio Pharmaceuticals Inc ARPO 99 15 2.98 -5.24 -28.77
Opiant Pharmaceuticals Inc OPNT 90 37 2.71 -86.08 -3.06
Natural Alternatives Internati NAII 89 169 1.26 10.07 5.68
VYNE Therapeutics Inc VYNE 72 16 1.08 3.27 -554.66
India Globalization Capital In IGC 67 0 2.39 -7.65 -981.18
Mannatech Inc MTEX 66 158 2.63 10.35 4.22
Acasti Pharma Inc ACST 42 0 1.81 -2.11 -611.47
Shineco Inc TYHT 36 14 1.85 -1.78 -159.60
Assertio Holdings Inc ASRT 33 117 0.45 -0.58 -38.05
Reviva Pharmaceuticals Holding RVPH 30 1.64 -4.74 None
Baudax Bio Inc BXRX 28 1 -11.98 0.84 None
Nabriva Therapeutics Plc NBRV 28 12 0.83 -0.47 -452.55
Bio-Path Holdings Inc BPTH 28 0 1.29 -2.68 18.96
Timber Pharmaceuticals Inc TMBR 26 0 11.39 0.88 -527.55
Trevi Therapeutics Inc TRVI 26 1.67 -0.74 None
Lexaria Bioscience Corp LEXX 25 1 3.49 -6.45 -445.15
Hoth Therapeutics Inc HOTH 22 1.85 -2.29 None
Cyanotech Corp. CYAN 17 34 0.99 13.57 3.83
Sonoma Pharmaceuticals Inc. SNOA 11 17 3.13 -2.04 -31.96

Tilray, Inc. (TLRY) Gains As Market Dips: What You Should Know

12h ago, source: Nasdaq

T ilray, Inc. (TLRY) closed at $12.17 in the latest trading session, marking a +1.33% move from the prior day. This move outpaced the S&P 500's daily loss of 0.91%. Coming into today, shares of the ...

Tilray, Inc. (TLRY) Dips More Than Broader Markets: What You Should Know

1d ago, source: Nasdaq

I n the latest trading session, Tilray, Inc. (TLRY) closed at $12.01, marking a -0.17% move from the previous day. This move lagged the S&P 500's daily loss of 0.16%. Coming into today, shares of the ...

Tilray Stock Attempts Bullish Reversal Following New Hampshire Legalization News

1d ago, source: Benzinga.com

Thousands of traders are getting a 90% win-rate trading options! Click Here to See How! Tilray Inc (NASDAQ: TLRY) broke up from a descending channel Benzinga called out but then fell down to backtest ...

Tilray Inc. (TLRY) Sitting On The Launch Pad, Waiting For Long Term Investors

1d ago, source: stocksregister

Tilray Inc. (NASDAQ:TLRY) price on Wednesday, September 15, rose 2.47% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $12.03. A look at the stock’s price ...

Tilray Bolsters Distribution Partnership With ROSE LifeScience In Quebec

15h ago, source: Benzinga.com

Tilray Inc.'s (NASDAQ:TLRY) (TSX:TLRY) is expanding its distribution partnership with Quebec-based ROSE LifeScience Inc through its subsidiary Tilray Canada Ltd. Under the deal, ROSE became an ...

Thinking About Buying Stock Or Options In Microsoft, Tilray Or Lululemon?

19h ago, source: Business Insider

One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It ...

Tilray Inc. (NASDAQ:TLRY) Is Down -13.05% Over The Past 30 Days: Is There Trouble Ahead?

7d ago, source: marketingsentinel

In recent trading session, Tilray Inc. (NASDAQ:TLRY) saw 7.91 million shares changing hands at last check today with its beta ...

ROSE LifeScience Announces Expanded Distribution Partnership with Tilray Canada

21h ago, source: YAHOO!Finance

ROSE LifeScience Inc. ("ROSE"), a local Quebec cannabis player, announced a partnership with Tilray Canada Ltd., a Canadian subsidiary of Tilray Inc. (TSX: TLRY), a leading global cannabis-lifestyle ...

Tilray Inc. (TLRY) Is A Buy Stock For Small Caps – Analysts

10d ago, source: marketingsentinel

Tilray Inc. (NASDAQ:TLRY) has seen 13.65 million shares traded in the last trading session. The company, currently valued at $6.22B, closed the last trade at $13.59 per share which meant it lost ...

Not A Good News For Tilray Inc. (NASDAQ: TLRY): Stock Could Even Fall -117.57%

4d ago, source: stocksregister

Tilray Inc. (NASDAQ:TLRY) price closed lower on Friday, September 10, dropping -3.50% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy ...

Tilray Stockholders Approve Increase In Number Of Shares To Help Drive $4B In Revenue, Stock Trades Down

7d ago, source: YAHOO!Finance

Shares of cannabis giant Tilray Inc. (NASDAQ: TLRY) (TSX: TLRY) are trading down on Friday afternoon, after the company ...

Your Portfolio